1naresh
Array ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) ) 1nareshArray ( [urn:ac.highwire.org:guest:identity] => Array ( [runtime-id] => urn:ac.highwire.org:guest:identity [type] => guest [service-id] => ajnr-ac.highwire.org [access-type] => Controlled [privilege] => Array ( [urn:ac.highwire.org:guest:privilege] => Array ( [runtime-id] => urn:ac.highwire.org:guest:privilege [type] => privilege-set [privilege-set] => GUEST ) ) [credentials] => Array ( [method] => guest ) ) )Table 1:Presence and distribution of the citrulline peak in patients with MS according to the VOI site revealed by 1H-MR Spectroscopy
Patient No. Citrulline Peak on 1H-MR Spectroscopy NAWM CDL EDL 1 + – na 2 na – – 3 na – na 4 + – – 5 – na na 6 + + na 7 + + na 8 – – na 9 + – na 10 – – + 11 – – na 12 – + – 13 + – na 14 – – – 15 – – – 16 – – na 17 – na na 18 + + – 19 – – na 20 – – na 21 + + – 22 – + na 23 – – na 24 – + na 25 – – na 26 – – na 27 – – na
Note:—na indicates that MR spectroscopy could not be performed due to absence of such a VOI site; +, present; –, absent; MS, multiple sclerosis; VOI, voxel of interest; NAWM, normal-appearing white matter; CDL, chronic demyelinating lesions; EDL, enhanced demyelinating lesions.